These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Acute renal failure due to high-grade obstruction following therapy with epsilon-aminocaproic acid. Pitts TO; Spero JA; Bontempo FA; Greenberg A Am J Kidney Dis; 1986 Dec; 8(6):441-4. PubMed ID: 3812474 [TBL] [Abstract][Full Text] [Related]
4. Unilateral essential hematuria. Therapy with epsilon aminocaproic acid. Nash DA; Henry AR Urology; 1984 Mar; 23(3):297-8. PubMed ID: 6702043 [TBL] [Abstract][Full Text] [Related]
5. Safe and effective, prolonged administration of epsilon aminocaproic acid in bleeding from the urinary tract. Stefanini M; English HA; Taylor AE J Urol; 1990 Mar; 143(3):559-61. PubMed ID: 2304169 [TBL] [Abstract][Full Text] [Related]
6. Use of epsilon aminocaproic acid in protracted bleeding from polycystic kidneys: a case report. Rao KV J Urol; 1986 Oct; 136(4):887-8. PubMed ID: 3761453 [TBL] [Abstract][Full Text] [Related]
7. Rhabdomyolysis during treatment with epsilon-aminocaproic acid. Britt CW; Light RR; Peters BH; Schochet SS Arch Neurol; 1980 Mar; 37(3):187-8. PubMed ID: 7356431 [TBL] [Abstract][Full Text] [Related]
8. Why may epsilon-aminocaproic acid (EACA) induce myopathy in man? Report of a case and literature review. Galassi G; Gibertoni M; Corradini L; Colombo A Ital J Neurol Sci; 1983 Dec; 4(4):489-92. PubMed ID: 6674249 [TBL] [Abstract][Full Text] [Related]
9. Epsilon-aminocaproic acid myopathy. Report of a case and literature review. Vanneste JA; van Wijngaarden GK Eur Neurol; 1982; 21(4):242-8. PubMed ID: 7117311 [TBL] [Abstract][Full Text] [Related]
10. Myonecrosis as a complication of the use of epsilon amino-caproic acid: a case report and review of the literature. Kane MJ; Silverman LR; Rand JH; Paciucci PA; Holland JF Am J Med; 1988 Dec; 85(6):861-3. PubMed ID: 3057905 [No Abstract] [Full Text] [Related]
11. Clot retention in the kidneys as a probable cause of anuria during treatment of haematuria with epsilon-aminocaproic acid. LindgÄrdh G; Andersson L Acta Med Scand; 1966 Oct; 180(4):469-73. PubMed ID: 5924536 [No Abstract] [Full Text] [Related]
12. Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases. MacKay AR; Sang U H; Weinstein PR J Neurosurg; 1978 Oct; 49(4):597-601. PubMed ID: 690689 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of ejaculation due to epsilon aminocaproic acid. Evans BE; Aledort LM N Engl J Med; 1978 Jan; 298(3):166-7. PubMed ID: 619254 [No Abstract] [Full Text] [Related]
15. Acute delirious state after epsilon-aminocaproic acid. Wysenbeek AJ; Sella A; Vardi M; Yeshurun D Lancet; 1978 Jan; 1(8057):221. PubMed ID: 74653 [No Abstract] [Full Text] [Related]
16. Purpuric rash due to epsilon-aminocaproic acid. Chakrabarti A; Collett KA Br Med J; 1980 Jul; 281(6234):197-8. PubMed ID: 6447530 [No Abstract] [Full Text] [Related]
17. [EXPERIMENTAL STUDY ON THE PROBLEM OF THE SIGNIFICANCE OF INTRAVASCULAR FIBRIN FORMATION IN THE OCCURRANCE OF ARTERIOSCLEROTIC CHANGES IN THE WALLS OF BLOOD VESSELS]. STUDER A; REBER K; LOREZ HP Pathol Microbiol (Basel); 1964; 27():287-302. PubMed ID: 14132881 [No Abstract] [Full Text] [Related]